Crystal Watson Selected Research

Crystal Watson Research Topics

9	Multiple Sclerosis 11/2018 - 01/2013
8	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2014 - 01/2010
8	Psoriatic Arthritis 04/2014 - 01/2010
8	Rheumatoid Arthritis 04/2014 - 01/2012
5	Ankylosing Spondylitis 04/2014 - 01/2012
2	Lymphoma (Lymphomas) 12/2020 - 12/2020
2	Hemophilia A (Haemophilia) 01/2020 - 12/2018
2	Relapsing-Remitting Multiple Sclerosis 04/2015 - 04/2014
1	Leukemia 01/2022
1	Cardiotoxicity 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Osteonecrosis (Kienbock's Disease) 01/2022
1	Infertility (Sterility) 01/2022
1	Infections 12/2020
1	Anemia 12/2020
1	Nausea 12/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2020
1	Thrombocytopenia (Thrombopenia) 12/2020
1	Vomiting 12/2020
1	Febrile Neutropenia 12/2020
1	Chronic Disease (Chronic Diseases) 12/2020
1	Injection Site Reaction 01/2018
1	Disease Progression 01/2017
1	Progressive Multifocal Leukoencephalopathy 04/2014

11	Etanercept (Enbrel)FDA Link 04/2014 - 01/2010
9	Adalimumab (Humira)FDA Link 04/2014 - 01/2012
7	Natalizumab (Tysabri)FDA Link 01/2017 - 01/2013
6	Infliximab (Remicade)FDA Link 04/2014 - 01/2012
4	Interferon-betaIBA 11/2018 - 10/2013
4	Tumor Necrosis Factor InhibitorsIBA 05/2013 - 01/2012
3	InterferonsIBA 11/2018 - 01/2018
2	Glatiramer Acetate (Copaxone)FDA Link 06/2015 - 10/2013
2	Fingolimod Hydrochloride (FTY720)FDA Link 04/2015 - 10/2013
2	Biological ProductsIBA 10/2013 - 01/2010
1	Hormones (Hormone)IBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020
1	Prednisone (Sone)FDA LinkGeneric 12/2020
1	Rituximab (Mabthera)FDA Link 12/2020
1	Vincristine (Oncovin)FDA LinkGeneric 12/2020
1	emicizumabIBA 01/2020
1	3'-(1-butylphosphoryl)adenosineIBA 12/2018
1	peginterferon beta-1aIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012
1	Antirheumatic Agents (DMARD)IBA 02/2012
1	3-methyl-N,N-diethyl-p-phenylenediamineIBA 01/2010